logo

Gw Pharmaceuticals Plc (GWP.L)



Trade GWP.L now with
  Date
  Headline
2/26/2021 7:16:12 AM GW Says EMA CHMP Adopted Positive Opinion On Type II Variation Application For EPIDYOLEX
2/3/2021 7:34:23 AM Jazz To Acquire GW Pharmaceuticals For Total Consideration Of $7.2 Bln, Or $6.7 Bln Net Of GW Cash
9/23/2020 4:00:59 AM GW Pharmaceuticals Gets Australian Therapeutic Goods Administration Approval For EPIDYOLEX
6/30/2020 7:14:46 AM GW Pharmaceuticals Announces Strategy For Bringing Nabiximols To U.S. Market
4/6/2020 9:10:27 AM GW Pharmaceuticals: EPIDIOLEX Oral Solution Has Been Descheduled And Is No Longer Controlled Substance
3/31/2020 7:17:48 AM GW Pharma: FDA Accept SNDA Filing With Priority Review For EPIDIOLEX
3/13/2020 7:06:55 AM GW Pharmaceuticals Submits Type II Variation Application To EMA To Expand Use Of EPIDYOLEX Oral Solution
3/2/2020 2:03:38 AM GW Pharmaceuticals Regains Exclusive Commercialisation Rights To Sativex In UK
2/3/2020 7:07:59 AM GW Pharma And Greenwich Biosciences Submit SNDA To FDA For Epidiolex
1/12/2020 8:04:16 PM GW Pharma Reports Q4 Total Preliminary Net Product Sales Of $108 Mln
12/5/2019 7:20:22 AM GW Pharmaceuticals To Present Variety Of Data At AES Annual Meeting